J.W. Cole Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

J.W. Cole Advisors, Inc.

  • $2.33 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $219,126 - $273,435
-2,950 Closed
0 $0
Q4 2021

Jan 25, 2022
SELL
$71.72 - $91.47 $139,854 - $178,366
-1,950 Reduced 39.8%
2,950 $261,000
Q3 2021

Oct 26, 2021
BUY
$74.77 - $85.47 $366,373 - $418,803
4,900 New
4,900 $379,000

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email